AEON Biopharma Files 8-K for Reg FD and Financials
Ticker: AEON · Form: 8-K · Filed: Mar 10, 2025 · CIK: 1837607
| Field | Detail |
|---|---|
| Company | Aeon Biopharma, INC. (AEON) |
| Form Type | 8-K |
| Filed Date | Mar 10, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-disclosure, financial-reporting
TL;DR
AEON Biopharma dropped an 8-K on March 10th covering Reg FD and financials.
AI Summary
AEON Biopharma, Inc. filed an 8-K on March 10, 2025, to report on a Regulation FD Disclosure and Financial Statements and Exhibits. The company, formerly known as Priveterra Acquisition Corp. until December 22, 2020, is incorporated in Delaware and headquartered in Irvine, California.
Why It Matters
This filing provides important updates on AEON Biopharma's regulatory compliance and financial reporting, which are crucial for investors to assess the company's current status.
Risk Assessment
Risk Level: low — This is a routine filing for financial statements and regulatory disclosures, not indicating any immediate operational or financial distress.
Key Players & Entities
- AEON Biopharma, Inc. (company) — Registrant
- Priveterra Acquisition Corp. (company) — Former company name
- March 10, 2025 (date) — Filing date
- Delaware (jurisdiction) — State of incorporation
- Irvine, CA (location) — Principal executive offices
FAQ
What specific Regulation FD disclosures are being made by AEON Biopharma in this 8-K?
The filing indicates a Regulation FD Disclosure item, but the specific details of the disclosure are not provided in the provided text excerpt.
What financial statements and exhibits are included with this 8-K filing?
The filing lists 'Financial Statements and Exhibits' as an item, but the specific content of these statements and exhibits is not detailed in the provided excerpt.
When did AEON Biopharma change its name from Priveterra Acquisition Corp.?
AEON Biopharma, Inc. changed its name from Priveterra Acquisition Corp. on December 22, 2020.
Where are AEON Biopharma's principal executive offices located?
AEON Biopharma's principal executive offices are located at 5 Park Plaza, Suite 1750, Irvine, CA 92614.
What is AEON Biopharma's IRS Employer Identification Number?
AEON Biopharma's IRS Employer Identification Number is 853940478.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 10, 2025 regarding AEON Biopharma, Inc. (AEON).